Small Molecules Targeting RNA

Paid

The coronavirus pandemic ignited interest in learning more about immune responses to infections, their downstream effects, and how they can be modulated. It also gave rise to increased awareness of the role of immunity in diseases like cancer, neurodegeneration, fibrosis, autoimmune disorders, and more. Cambridge Healthtech Institute’s symposium on

26-27 September 2023

Healthcare

Protein Degraders and Molecular Glues – Part 1

Paid

A new generation of molecules are being developed to disrupt protein-protein interactions and to hijack the cell’s natural machinery for targeted protein degradation. Proteolysis-targeting chimeras (PROTACs), molecular glues, and other modalities are utilizing the ubiquitin-proteasome, lysosome, and autophagy systems to seek out previously “undrugg

26-27 September 2023

Healthcare